肥胖小鼠模型标准化的重要性
Title:
Microbiome and metabolic disorders related to obesity: which lessons to learn from experimental models?
DOI:
10.1016/j.tifs.2016.08.012
Abstract:
Background: Dysbiosis, meaning alterations of the gut microbiota composition or function, has been related to obesity and metabolic diseases. Experimental models of obesity in mice suggest the involvement of microbiota in the modulation of gut immunity, gut barrier and gut endocrine function. However, discrepancies exist between data reported in different studies. Scope and Approach: Taking into account the published data relating gut microbiota analysis and host metabolism in models of high fat diet induced obesity, one of the objective is to point out the rationale for choosing the adequate experimental model allowing to recapitulate dysbiosis and metabolic diseases, with a focus on data related to gut endocrine function and immunity in the context of obesity. Key Findings and Conclusions: Efforts are needed to standardize the experimental models of obesity allowing to evaluate how dysbiosis is assessed taking into account the adequate control diet, the choice of the genetic background following the question addressed and the duration of the treatment. Those parameters must be defined before proposing preclinical models to evaluate the relevance of probiotic or prebiotic approaches in the control of obesity and related metabolic diseases.
All Authors:
Audrey M Neyrinck,Valentina L Schüppel,Trevor Lockett,Dirk Haller,Nathalie M Delzenne
First Authors:
Audrey M Neyrinck
Correspondence:
Nathalie M Delzenne
内容要点:
1、肠道菌群组成及功能的失调与肥胖及代谢疾病相关;
2、肥胖小鼠模型中的实验证据表明菌群参与调节肠道免疫、肠道功能屏障、肠道内分泌功能;
3、然而不同的研究中的报道存在差异;
4、选择合适的小鼠模型十分重要,未来在研究肥胖及代谢疾病与菌群失调及饮食的关系时,需要肥胖小鼠模型及实验流程的标准化。
- 上一条:肠道菌群与婴幼儿过敏及哮喘密切相关
- 下一条:粪菌移植有助于恢复经抗生素破坏的菌群